Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065431271> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2065431271 endingPage "464" @default.
- W2065431271 startingPage "460" @default.
- W2065431271 abstract "Because of its ability to block 5-HT2 receptors postsynaptically and inhibit 5-HT reuptake presynaptically and/or its enhancement of sleep quality, nefazodone may be useful for symptom management in posttraumatic stress disorder (PTSD) patients.Ten patients with combat-related DSM-IV posttraumatic stress disorder (PTSD) entered an open-label 12-week trial of nefazodone with a 4-week follow-up, beginning with 100 mg/day and increasing as necessary to achieve a maximal response or until reaching a maximum dosage of 600 mg/day.Nefazodone was well tolerated, and no significant changes in sexual function were reported. Based on Clinical Global Impressions-Improvement scores, all 10 patients were rated as much improved. All PTSD symptoms (except self-reported PTSD reexperiencing symptoms), sleep, and clinician-rated depression significantly improved at week 12. At follow-up, significant changes were maintained, and self-reported PTSD reexperiencing symptoms had also significantly improved. Effect sizes for all changed symptoms were moderate to large at week 12 and at follow-up. Self-reported and clinician-rated anger significantly improved. Self-reported depression failed to improve. Improvement in social and occupational functioning was minimal.These preliminary data suggest that nefazodone may be effective in reducing the 3 primary PTSD symptom clusters and may be particularly helpful in improving sleep and decreasing anger." @default.
- W2065431271 created "2016-06-24" @default.
- W2065431271 creator A5045667588 @default.
- W2065431271 creator A5059343004 @default.
- W2065431271 creator A5060793191 @default.
- W2065431271 creator A5068102918 @default.
- W2065431271 creator A5073138616 @default.
- W2065431271 date "1998-09-15" @default.
- W2065431271 modified "2023-10-12" @default.
- W2065431271 title "Open Trial of Nefazodone for Combat-Related Posttraumatic Stress Disorder" @default.
- W2065431271 doi "https://doi.org/10.4088/jcp.v59n0904" @default.
- W2065431271 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9771816" @default.
- W2065431271 hasPublicationYear "1998" @default.
- W2065431271 type Work @default.
- W2065431271 sameAs 2065431271 @default.
- W2065431271 citedByCount "65" @default.
- W2065431271 countsByYear W20654312712015 @default.
- W2065431271 countsByYear W20654312712016 @default.
- W2065431271 countsByYear W20654312712018 @default.
- W2065431271 countsByYear W20654312712019 @default.
- W2065431271 countsByYear W20654312712022 @default.
- W2065431271 countsByYear W20654312712023 @default.
- W2065431271 crossrefType "journal-article" @default.
- W2065431271 hasAuthorship W2065431271A5045667588 @default.
- W2065431271 hasAuthorship W2065431271A5059343004 @default.
- W2065431271 hasAuthorship W2065431271A5060793191 @default.
- W2065431271 hasAuthorship W2065431271A5068102918 @default.
- W2065431271 hasAuthorship W2065431271A5073138616 @default.
- W2065431271 hasConcept C118552586 @default.
- W2065431271 hasConcept C126322002 @default.
- W2065431271 hasConcept C139719470 @default.
- W2065431271 hasConcept C15744967 @default.
- W2065431271 hasConcept C162324750 @default.
- W2065431271 hasConcept C170493617 @default.
- W2065431271 hasConcept C2775864247 @default.
- W2065431271 hasConcept C2776134451 @default.
- W2065431271 hasConcept C2776867660 @default.
- W2065431271 hasConcept C2779302386 @default.
- W2065431271 hasConcept C2779419675 @default.
- W2065431271 hasConcept C2991847609 @default.
- W2065431271 hasConcept C70410870 @default.
- W2065431271 hasConcept C71924100 @default.
- W2065431271 hasConceptScore W2065431271C118552586 @default.
- W2065431271 hasConceptScore W2065431271C126322002 @default.
- W2065431271 hasConceptScore W2065431271C139719470 @default.
- W2065431271 hasConceptScore W2065431271C15744967 @default.
- W2065431271 hasConceptScore W2065431271C162324750 @default.
- W2065431271 hasConceptScore W2065431271C170493617 @default.
- W2065431271 hasConceptScore W2065431271C2775864247 @default.
- W2065431271 hasConceptScore W2065431271C2776134451 @default.
- W2065431271 hasConceptScore W2065431271C2776867660 @default.
- W2065431271 hasConceptScore W2065431271C2779302386 @default.
- W2065431271 hasConceptScore W2065431271C2779419675 @default.
- W2065431271 hasConceptScore W2065431271C2991847609 @default.
- W2065431271 hasConceptScore W2065431271C70410870 @default.
- W2065431271 hasConceptScore W2065431271C71924100 @default.
- W2065431271 hasIssue "9" @default.
- W2065431271 hasLocation W20654312711 @default.
- W2065431271 hasLocation W20654312712 @default.
- W2065431271 hasOpenAccess W2065431271 @default.
- W2065431271 hasPrimaryLocation W20654312711 @default.
- W2065431271 hasRelatedWork W1964613158 @default.
- W2065431271 hasRelatedWork W2032036822 @default.
- W2065431271 hasRelatedWork W2043454131 @default.
- W2065431271 hasRelatedWork W2044100613 @default.
- W2065431271 hasRelatedWork W233851105 @default.
- W2065431271 hasRelatedWork W2604463491 @default.
- W2065431271 hasRelatedWork W2913857178 @default.
- W2065431271 hasRelatedWork W2923020031 @default.
- W2065431271 hasRelatedWork W4231285922 @default.
- W2065431271 hasRelatedWork W44455618 @default.
- W2065431271 hasVolume "59" @default.
- W2065431271 isParatext "false" @default.
- W2065431271 isRetracted "false" @default.
- W2065431271 magId "2065431271" @default.
- W2065431271 workType "article" @default.